Immutep
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
IMMP Key Statistics
Stock Snapshot
As of today, Immutep(IMMP) shares are valued at $2.45. The company's market cap stands at 373.04M, with a P/E ratio of -9.16.
On 2025-12-17, Immutep(IMMP) stock moved within a range of $2.43 to $2.55. With shares now at $2.45, the stock is trading +1.2% above its intraday low and -3.9% below the session's peak.
Trading activity shows a volume of 244.62K, compared to an average daily volume of 3.34M.
Over the past 52 weeks, Immutep(IMMP) stock has traded between a high of $3.53 and a low of $1.32.
Over the past 52 weeks, Immutep(IMMP) stock has traded between a high of $3.53 and a low of $1.32.
IMMP News
Immutep (IMMP) reports strong operational progress in the TACTI-004 Phase III trial evaluating eftilagimod alfa in combination with MSD’s (MRK) anti-PD-1 therap...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...